Molecular biological markers and micrometastasis in resected non-small-cell lung cancer
Authors:
- 1 September 2001
- journal article
- research article
- Published by Springer Nature in The Japanese Journal of Thoracic and Cardiovascular Surgery
- Vol. 49 (9) , 545-551
Abstract
Objectives: Recent advances in molecular biology and genetics have created new diagnostic and treatment possibilities in clinical oncology. We evaluated the usefulness of molecular biological factors in primary tumor and micrometastasis in the bone marrow and pathological negative (pN0) lymph nodes as prognostic parameters in non-small-cell lung cancer (NSCLC) patients.Methods: Pathological specimens were collected from 129 NSCLC patients to analyze molecular biological markers, including K-ras, p53, Rb, p16, loss of heterozygosity (LOH) at 3p, vascular endothelial growth factor (VEGF), and telomerase activity. Bone marrow samples from 250 NSCLC patients and pN0 lymph nodes from 85 of these patients were collected for micrometastasis detection by immunohistochemistry against cytokeratin.Results: p53 abnormalities and 3p LOH were significantly associated with reduced patient survival in adenocarcinoma, whereas VEGF expression was significantly associated with reduced survival in a squamous cell carcinoma histological subtype by univariate or multivariate analysis. We identified micrometastatic tumor cells in bone marrow of 78 (31.2%) of 250 patients and in pN0 lymph nodes of 26 (30.6%) of 85 patients. Both bone marrow and lymph nodal micrometastases wer associated with decreased survival among patients with stage I, however, only lymph nodal micrometastasis had a significant impact on survival.Conclusions: Molecular biological features of primary tumor and micrometastatic status appear useful in defining groups of patients with a poor prognosis who could benefit from adjuvant systemic treatment.Keywords
This publication has 30 references indexed in Scilit:
- Micrometastatic p53-positive cells in the lymph nodes of non-small-cell lung cancer: Prognostic significanceThe Journal of Thoracic and Cardiovascular Surgery, 1997
- Micrometastatic tumor cells in the bone marrow of patients with non-small cell lung cancerThe Annals of Thoracic Surgery, 1997
- Reverse transcriptase/polymerase chain reaction detection of cytokeratin-19 mRNA in bone marrow and blood of breast cancer patientsJournal of Cancer Research and Clinical Oncology, 1996
- Frequent loss of the short arm of chromosome 9 in resected non-small-cell lung cancers from Japanese patients and its association with squamous cell carcinomaJournal of Cancer Research and Clinical Oncology, 1995
- Specific Association of Human Telomerase Activity with Immortal Cells and CancerScience, 1994
- C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas.Journal of Clinical Investigation, 1994
- Frequency and Distribution of Occult Micrometastases in Lymph Nodes of Patients With Non-Small-Cell Lung CarcinomaJNCI: Journal of the National Cancer Institute, 1993
- Induction of angiogenesis during the transition from hyperplasia to neoplasiaNature, 1989
- Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).Journal of Histochemistry & Cytochemistry, 1984
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958